Berylson Capital Partners, LLC Kala Pharmaceuticals, Inc. Transaction History

Berylson Capital Partners, LLC

  • $39.6 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$4.29 - $9.94 $261,690 - $606,340
-61,000 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$13.68 - $23.17 $834,480 - $1.41 Million
61,000
61,000 $1.13 Million

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $10.1M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Berylson Capital Partners, LLC Portfolio

Follow Berylson Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berylson Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berylson Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email